129 related articles for article (PubMed ID: 27984402)
21. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
22. An Urban Center Experience Exploring Barriers to Adherence to Endoscopic Surveillance for Non-Dysplastic Barrett's Esophagus.
Isseh M; Mueller L; Abunafeesa H; Imam Z; Shakaroun D; Abu Ghanimeh M; Isseh N; Miller J; Jafri SM; Lenhart A
Cureus; 2021 Jan; 13(1):e13030. PubMed ID: 33665052
[TBL] [Abstract][Full Text] [Related]
23. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines.
Wani S; Williams JL; Falk GW; Komanduri S; Muthusamy VR; Shaheen NJ
Am J Gastroenterol; 2020 Nov; 115(11):1869-1878. PubMed ID: 33156106
[TBL] [Abstract][Full Text] [Related]
24. Racial Disparities in Adherence to Quality Indicators in Barrett's Esophagus: An Analysis Using the GIQuIC National Benchmarking Registry.
Jones B; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ; Wani S
Am J Gastroenterol; 2021 Jun; 116(6):1201-1210. PubMed ID: 33767105
[TBL] [Abstract][Full Text] [Related]
25. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
Vieth M; Schubert B; Lang-Schwarz K; Stolte M
Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
[TBL] [Abstract][Full Text] [Related]
26. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
[TBL] [Abstract][Full Text] [Related]
27. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
[TBL] [Abstract][Full Text] [Related]
28. Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States.
Abrams JA; Kapel RC; Lindberg GM; Saboorian MH; Genta RM; Neugut AI; Lightdale CJ
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):736-42; quiz 710. PubMed ID: 19268726
[TBL] [Abstract][Full Text] [Related]
29. Influence of body mass index on the prevalence and progression of dysplasia in Barrett's esophagus: a retrospective analysis (.).
Thota PN; Arora Z; Benjamin T; Pagadala M; Lopez R; Sanaka MR
Scand J Gastroenterol; 2016 Nov; 51(11):1288-93. PubMed ID: 27460942
[TBL] [Abstract][Full Text] [Related]
30. Statin use is associated with a decreased risk of Barrett's esophagus.
Nguyen T; Khalaf N; Ramsey D; El-Serag HB
Gastroenterology; 2014 Aug; 147(2):314-23. PubMed ID: 24798416
[TBL] [Abstract][Full Text] [Related]
31. Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance.
Gatenby P; Bhattacharjee S; Wall C; Caygill C; Watson A
World J Gastroenterol; 2016 Dec; 22(48):10592-10600. PubMed ID: 28082811
[TBL] [Abstract][Full Text] [Related]
32. Treatment Outcomes of Endoscopic Submucosal Dissection for Adenocarcinoma Originating from Long-Segment Barrett's Esophagus versus Short-Segment Barrett's Esophagus.
Shimizu T; Fujisaki J; Omae M; Yamasaki A; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T
Digestion; 2018; 97(4):316-323. PubMed ID: 29539629
[TBL] [Abstract][Full Text] [Related]
33. The frequency of Barrett's esophagus in high-risk patients with chronic GERD.
Westhoff B; Brotze S; Weston A; McElhinney C; Cherian R; Mayo MS; Smith HJ; Sharma P
Gastrointest Endosc; 2005 Feb; 61(2):226-31. PubMed ID: 15729230
[TBL] [Abstract][Full Text] [Related]
34. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines.
van Sandick JW; Bartelsman JF; van Lanschot JJ; Tytgat GN; Obertop H
Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):111-7. PubMed ID: 10656220
[TBL] [Abstract][Full Text] [Related]
35. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
[TBL] [Abstract][Full Text] [Related]
37. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
[TBL] [Abstract][Full Text] [Related]
38. Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia.
Benipal P; Garewal HS; Sampliner RE; Martinez P; Hayden CW; Fass R
Am J Gastroenterol; 2001 Nov; 96(11):3084-8. PubMed ID: 11721753
[TBL] [Abstract][Full Text] [Related]
39. Barrett's surveillance identifies patients with early esophageal adenocarcinoma.
Wong T; Tian J; Nagar AB
Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324
[TBL] [Abstract][Full Text] [Related]
40. Physician Non-adherence to Colonoscopy Interval Guidelines in the Veterans Affairs Healthcare System.
Johnson MR; Grubber J; Grambow SC; Maciejewski ML; Dunn-Thomas T; Provenzale D; Fisher DA
Gastroenterology; 2015 Oct; 149(4):938-51. PubMed ID: 26122143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
